These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 9374774

  • 1. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
    Rademaker MT, Charles CJ, Kosoglou T, Protter AA, Espiner EA, Nicholls MG, Richards AM.
    Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774
    [Abstract] [Full Text] [Related]

  • 2. Clearance receptors and endopeptidase 24.11: equal role in natriuretic peptide metabolism in conscious sheep.
    Charles CJ, Espiner EA, Nicholls MG, Richards AM, Yandle TG, Protter A, Kosoglou T.
    Am J Physiol; 1996 Aug; 271(2 Pt 2):R373-80. PubMed ID: 8770137
    [Abstract] [Full Text] [Related]

  • 3. Natriuretic peptide analogues with distinct vasodilatory or renal activity: integrated effects in health and experimental heart failure.
    Rademaker MT, Scott NJA, Koh CY, Kini RM, Richards AM.
    Cardiovasc Res; 2021 Jan 21; 117(2):508-519. PubMed ID: 32167565
    [Abstract] [Full Text] [Related]

  • 4. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
    Hunt PJ, Espiner EA, Nicholls MG, Richards AM, Yandle TG.
    J Clin Endocrinol Metab; 1996 Nov 21; 81(11):3871-6. PubMed ID: 8923831
    [Abstract] [Full Text] [Related]

  • 5. Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure.
    Rademaker MT, Charles CJ, Espiner EA, Nicholls MG, Richards AM, Kosoglou T.
    Clin Sci (Lond); 1996 Sep 21; 91(3):283-91. PubMed ID: 8869410
    [Abstract] [Full Text] [Related]

  • 6. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
    Kukkonen P, Vuolteenaho O, Ruskoaho H.
    Endocrinology; 1992 Feb 21; 130(2):755-65. PubMed ID: 1531129
    [Abstract] [Full Text] [Related]

  • 7. Combined endopeptidase inhibition and adrenomedullin in sheep with experimental heart failure.
    Rademaker MT, Charles CJ, Cooper GJ, Coy DH, Espiner EA, Lewis LK, Nicholls MG, Richards AM.
    Hypertension; 2002 Jan 21; 39(1):93-8. PubMed ID: 11799085
    [Abstract] [Full Text] [Related]

  • 8. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
    Hirata Y, Matsuoka H, Suzuki E, Hayakawa H, Sugimoto T, Matsuda Y, Morishita Y, Kangawa K, Minamino N, Matsuo H.
    Circulation; 1993 Feb 21; 87(2):554-61. PubMed ID: 8381060
    [Abstract] [Full Text] [Related]

  • 9. Comparative bioactivity of atrial and brain natriuretic peptides in an ovine model of heart failure.
    Rademaker MT, Charles CJ, Espiner EA, Frampton CM, Nicholls MG, Richards AM.
    Clin Sci (Lond); 1997 Feb 21; 92(2):159-65. PubMed ID: 9059317
    [Abstract] [Full Text] [Related]

  • 10. Bioactivity of natriuretic peptide coinfusions; no evidence for unique effects of BNP in conscious sheep.
    Charles CJ, Espiner EA, Nicholls MG, Rademaker MT, Richards AM.
    J Cardiovasc Pharmacol; 1999 Feb 21; 33(2):229-36. PubMed ID: 10028930
    [Abstract] [Full Text] [Related]

  • 11. Acute hemodynamic, hormonal, and renal effects of neutral endopeptidase inhibition in ovine heart failure.
    Fitzpatrick MA, Rademaker MT, Charles CJ, Yandle TG, Espiner EA, Ikram H, Sybertz E.
    J Cardiovasc Pharmacol; 1992 Apr 21; 19(4):635-40. PubMed ID: 1380608
    [Abstract] [Full Text] [Related]

  • 12. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
    Wilkins MR, Settle SL, Kirk JE, Taylor SA, Moore KP, Unwin RJ.
    Br J Pharmacol; 1992 Sep 21; 107(1):50-7. PubMed ID: 1330165
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
    Borgeson DD, Stevens TL, Heublein DM, Matsuda Y, Burnett JC.
    Clin Sci (Lond); 1998 Aug 21; 95(2):195-202. PubMed ID: 9680502
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of neutral endopeptidase inhibitor in rats with congestive heart failure.
    Murohara Y, Johnston CI.
    Clin Exp Pharmacol Physiol; 1992 May 21; 19(5):380-3. PubMed ID: 1325886
    [Abstract] [Full Text] [Related]

  • 17. Comparative bioactivity of atrial, brain, and C-type natriuretic peptides in conscious sheep.
    Charles CJ, Espiner EA, Richards AM, Nicholls MG, Yandle TG.
    Am J Physiol; 1996 Jun 21; 270(6 Pt 2):R1324-31. PubMed ID: 8764300
    [Abstract] [Full Text] [Related]

  • 18. Interactions of atrial and brain natriuretic peptides at pathophysiological levels in normal men.
    Hunt PJ, Espiner EA, Richards AM, Yandle TG, Frampton C, Nicholls MG.
    Am J Physiol; 1995 Dec 21; 269(6 Pt 2):R1397-403. PubMed ID: 8594942
    [Abstract] [Full Text] [Related]

  • 19. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
    Wegner M, Ganten D, Stasch JP.
    Hypertens Res; 1996 Dec 21; 19(4):229-38. PubMed ID: 8986453
    [Abstract] [Full Text] [Related]

  • 20. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor.
    Silberbach M, Woods LL, Hohimer AR, Shiota T, Matsuda Y, Davis LE.
    Pediatr Res; 1995 Nov 21; 38(5):722-8. PubMed ID: 8552440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.